Skip to Content

Danaher Corp

DHR: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$713.00LycncCfhlnbsy

Danaher Earnings: Strong Start to 2024 Boosts Our Fair Value Estimate

Narrow-moat Danaher started strong in 2024 primarily on the strength of its Cepheid diagnostic business, although positive signs are coming out of its other segments, too. We are raising our fair value estimate for Danaher 5% to $255 per share from $243 to reflect this strong start and cash flows generated since our last valuation update.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of DHR so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center